We examined the ability of a new combined nitric oxide (NO)/nitrogen dioxide (NO 2 ) electrochemical analyser (PrinterNOx, Micro Medical Limited, Chatham, Kent, England) to measure NO and NO 2 concentrations.
The administration of nitric oxide (NO) to critically ill patients is a relatively new technique. Delivered concentrations of both NO and the by-product nitrogen dioxide (NO 2 ), formed after reaction with oxygen (O 2 ), should be monitored. A new electrochemical monitor (PrinterNOx, Micro Medical Limited, Chatham, Kent, England also sold as the SensorNOx, Sensormedics Corporation, CA, U.S.A.) has recently become available. In this study we compare its performance to that of a chemiluminescence analyser (42H, Thermo Environmental Instruments Inc. Franklin, MA, U.S.A.).
MATERIALS AND METHODS
A Servo 900C ventilator (Siemens Elema, Sweden) was used in conjunction with a heated humidifier (MR600, Fisher & Paykel Healthcare, Auckland, New Zealand) set to 37°C with a MR320 humidification chamber without water. Ventilator settings were: minute volume 2.5 l/min, 20 bpm, inspiratory time of 25%, pause time 10% and 0 cmH 2 O PEEP. An artificial infant lung (260li, Adult/Infant TTL Test Lung, Michigan Instruments Inc, MI, U.S.A.) was used with airway resistance of 50 cmH 2 O/l/sec and compliance of 0.005 l/cmH 2 O. Peak airway pressure measured at the test lung was 15 cmH 2 O with 0 cmH 2 O PEEP. MAP was 5.4 cmH 2 O. Expired gas was scavenged using a Servo Evac 180 (Siemens Elema, Sweden).
Blended O 2 and NO were mixed and supplied to the low pressure inlet of the ventilator as previously described 1 , using a blender (Bird Products Corporation, CA, U.S.A.) and a 0 to 14 l/min O 2 flow meter (Ohmeda, Tullamarine, Victoria). F i O 2 was 0.60. NO was supplied from a source cylinder (917±18 ppm NO, 936±19 ppm NOx, BOC Gases, Preston, Victoria) using a 0 to 1 l/min or 0 to 5 l/min air flowmeter (Precision Medical Inc, PA, U.S.A.).
Measurements of NO and NO 2 obtained from the PrinterNOx (PNOx) were compared to those obtained from the chemiluminescence analyser (CHEM). Both analysers were calibrated with ex-posure to 89.3±1.8 ppm NO and 90.8±1.8 ppm NOx (total oxides of nitrogen) (BOC Gases, Preston, Victoria). The sampling line for the CHEM was placed 14 cm from the patient connection on the expiratory side of the circuit. The sampling line for the PNOx was placed a further 70 cm along the expiratory circuit.
The standard analysis using the methods recommended by Bland and Altman 2 to analyse the differences between two techniques purporting to measure the same parameter was not appropriate in this case because the differences changed linearly with increasing NO and NO 2 concentrations. It was therefore necessary to use regression analysis to best describe and quantify the results. Regression analyses were performed using the Excel program (v5.0 Microsoft Corporation, U.S.A.).
RESULTS
Forty-four paired NO measurements and 50 paired NO 2 measurements were obtained. NO ranged from 2.56 ppm to 64.1 ppm on the chemiluminescence analyser and 2.7 ppm to 74.6 ppm on the PrinterNOx. NO 2 ranged from 0.05 ppm to 5.39 ppm on the chemiluminescence analyser and 0.0 ppm to 4.6 ppm on the PrinterNOx.
The relationship between the chemiluminescence analyser and the PrinterNOx for the measurement of NO is shown in Figure 1a with an accompanying Bland-Altman plot shown in Figure 1b . The equation for the regression line is PNOx=1.1658 (CHEM) +0.0197 (r 2 =0.9981). If the analysis is restricted to NO concentrations in the clinically more appropriate range of 0-25 ppm, a very linear relationship is obtained (Figure 2a and 2b) . The regression equation for this relationship is PNOx=1.1984 (CHEM) -0.4657 (r 2 =0.9996).
The relationship between the PrinterNOx and the chemiluminescence analyser for the measurement of NO 2 are shown in Figures 3a and 3b . The equation for the regression line is PNOx=0.879 (CHEM) -0.0447 (r 2 =0.9993).
DISCUSSION
The NO measurements obtained with the PrinterNO x analyser used in this study were very closely related to the chemiluminescence analyser with r 2 =0.9981 over the range 0-70 ppm and 0.9996 over the range 0-25 ppm. The difference between the PrinterNO x and the chemiluminescence analyser increased as nitric oxide levels increased and made the use of the standard Bland and Altman analysis 2 inadequate. In fact, in the range 0-25 ppm NO the relationship between the two analysers was very The relationship between the two analysers for the measurement of NO concentration could reflect the performance of the chemiluminescence analyser. When compared to nitric oxide concentrations calculated using gas flow rates however, the PrinterNOx showed the same tendency to overestimate while the chemiluminescence analyser did not. The characteristic of some electrochemical sensors to show this proportional difference to measurements using a chemiluminescence analyser is also evident in other studies [3] [4] [5] . A recent study 5 reported similar results to those found in the current study with two different electrochemical sensors showing increasing overestimation of NO compared to a chemiluminescence analyser although one analyser underestimated the chemiluminescence analyser in the 0-30 ppm range. Some other studies also show an increasing underestimation of NO by other electrochemical sensors 4, 6 . It is interesting that when comparing the same electrochemical device to different chemiluminescence analysers Mercier 3 found that it overestimated chemiluminescence readings in an F i O 2 of 1.0 while Moutafis 6 found it to underestimate in air but slightly overestimate in an elevated F i O 2 as found in the current study.
For the measurement of NO 2 , the PrinterNOx underestimated the NO 2 level measured by the chemiluminescence analyser by 13.8% over the range 0.05 ppm to 5.39 ppm. This is particularly important given the need to limit NO 2 exposure to <5 ppm. A lower level (4.33 ppm) would need to be observed in order to provide the same protection if the PrinterNOx was used in place of the chemiluminescence analyser.
The current study is not without limitations. We did not test for the influence of F i O 2 or mean airway pressure, both of which are known to influence some analysers [7] [8] [9] . We also tested with unhumidified gases. This is not the typical situation on the expiratory side of the circuit in clinical practice. It is our clinical practice however, to sample from the unhumidified part of the inspiratory circuit to avoid contaminating the chemiluminescence analyser with water.
With the increase in use and proven value of NO therapy it is important that appropriate monitoring is available and used. Electrochemical devices are likely to be more readily used in the clinical setting because of their smaller size and quiet operation. The PrinterNO x is small, easy to use and calibrate. Our results show that it has sufficient accuracy to be of clinical use in the administration of NO.
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